Vanda Pharmaceuticals | VNDA - Stock

Stock Price
7.27
Daily Change
-0.05 -0.68%
Monthly
-17.48%
Yearly
66.36%
Q2 Forecast
7.02

Vanda Pharmaceuticals reported $1.85M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Akebia Therapeutics USD 15.61M 3.03M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Anika Therapeutics USD 18.79M 2.5M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.59B 126M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.07M 11.1M Dec/2025
J&J USD 14.19B 45M Dec/2025
Lexicon Pharmaceuticals USD 168K 33K Jun/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Takeda JPY 1.41T 107.71B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025
Veracyte USD 20.55M 219K Dec/2025